Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropsychopharmacology ; 40(8): 1856-65, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25652247

ABSTRACT

The central melanocortin (MC) system has been widely studied for its effects on food intake and sexual behavior. However, the MC system, and more specifically the MC4 receptor (MC4R), also interacts with neurochemical systems that regulate socioemotional behaviors, including oxytocin (OT) and dopamine. In monogamous prairie voles, OT and dopamine interact to promote partner preference formation, a laboratory measure of an enduring social bond between mates. Here we investigated the effects of MC receptor activation on partner preference formation in prairie voles, as well as the interaction between the MC and OT systems during this process. Peripheral administration of the brain penetrant MC3/4R receptor peptide agonist, Melanotan II (MTII), and the highly selective, small-molecule MC4R agonist, Pf-446687, enhanced partner preference formation in the prairie vole, but not in the non-monogamous meadow vole. MTII-induced partner preferences were enduring, as they were present 1 week after drug manipulation. The prosocial effects of MCR agonists may be mediated, in part, through modulation of OT, as coadministration of an OT receptor antagonist prevented MTII-induced partner preferences. MTII also selectively activated hypothalamic OT neurons and potentiated central OT release. As OT has been shown to enhance some aspects of social cognition in humans, our data suggest that the MC4R may be a viable therapeutic target for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia, potentially through activation of the OT system.


Subject(s)
Oxytocin/metabolism , Pair Bond , Receptors, Melanocortin/agonists , Sexual Behavior, Animal/drug effects , alpha-MSH/analogs & derivatives , Animals , Arginine Vasopressin/antagonists & inhibitors , Arginine Vasopressin/metabolism , Arvicolinae , Brain/drug effects , Brain/metabolism , Dose-Response Relationship, Drug , Early Growth Response Protein 1/metabolism , Female , Male , Oxytocin/pharmacology , Peptides, Cyclic/pharmacology , Piperidines/pharmacology , Pyrrolidines/pharmacology , Receptors, Melanocortin/genetics , Receptors, Melanocortin/metabolism , Receptors, Oxytocin/agonists , Receptors, Oxytocin/genetics , Receptors, Oxytocin/metabolism , Sex Characteristics , Vasotocin/analogs & derivatives , Vasotocin/pharmacology , alpha-MSH/pharmacology
2.
Nat Commun ; 5: 4510, 2014 Jul 29.
Article in English | MEDLINE | ID: mdl-25072471

ABSTRACT

The subcellular localization and translation of messenger RNA (mRNA) supports functional differentiation between cellular compartments. In neuronal dendrites, local translation of mRNA provides a rapid and specific mechanism for synaptic plasticity and memory formation, and might be involved in the pathophysiology of certain brain disorders. Despite the importance of dendritic mRNA translation, little is known about which mRNAs can be translated in dendrites in vivo and when their translation occurs. Here we collect ribosome-bound mRNA from the dendrites of CA1 pyramidal neurons in the adult mouse hippocampus. We find that dendritic mRNA rapidly associates with ribosomes following a novel experience consisting of a contextual fear conditioning trial. High throughput RNA sequencing followed by machine learning classification reveals an unexpected breadth of ribosome-bound dendritic mRNAs, including mRNAs expected to be entirely somatic. Our findings are in agreement with a mechanism of synaptic plasticity that engages the acute local translation of functionally diverse dendritic mRNAs.


Subject(s)
Dendrites/physiology , Models, Neurological , Neuronal Plasticity/physiology , Protein Biosynthesis/physiology , Pyramidal Cells/physiology , RNA, Messenger/metabolism , Ribosomes/metabolism , Animals , Base Sequence , Conditioning, Psychological , Dendrites/metabolism , Fear , High-Throughput Nucleotide Sequencing , Hippocampus/cytology , Image Processing, Computer-Assisted , Immunohistochemistry , In Situ Hybridization, Fluorescence , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment
3.
PLoS One ; 7(1): e29940, 2012.
Article in English | MEDLINE | ID: mdl-22238679

ABSTRACT

Memory loss is one of the hallmark symptoms of Alzheimer's disease (AD). It has been proposed that soluble amyloid-beta (Abeta) oligomers acutely impair neuronal function and thereby memory. We here report that natural Abeta oligomers acutely impair contextual fear memory in mice. A natural Abeta oligomer solution containing Abeta monomers, dimers, trimers, and tetramers was derived from the conditioned medium of 7PA2 cells, a cell line that expresses human amyloid precursor protein containing the Val717Phe familial AD mutation. As a control we used 7PA2 conditioned medium from which Abeta oligomers were removed through immunodepletion. Separate groups of mice were injected with Abeta and control solutions through a cannula into the lateral brain ventricle, and subjected to fear conditioning using two tone-shock pairings. One day after fear conditioning, mice were tested for contextual fear memory and tone fear memory in separate retrieval trials. Three experiments were performed. For experiment 1, mice were injected three times: 1 hour before and 3 hours after fear conditioning, and 1 hour before context retrieval. For experiments 2 and 3, mice were injected a single time at 1 hour and 2 hours before fear conditioning respectively. In all three experiments there was no effect on tone fear memory. Injection of Abeta 1 hour before fear conditioning, but not 2 hours before fear conditioning, impaired the formation of a contextual fear memory. In future studies, the acute effect of natural Abeta oligomers on contextual fear memory can be used to identify potential mechanisms and treatments of AD associated memory loss.


Subject(s)
Amyloid beta-Peptides/pharmacology , Avoidance Learning/drug effects , Fear/drug effects , Fear/psychology , Memory/drug effects , Algorithms , Amyloid beta-Peptides/metabolism , Animals , Avoidance Learning/physiology , CHO Cells , Cricetinae , Cricetulus , Fear/physiology , Male , Memory/physiology , Memory Disorders/chemically induced , Memory Disorders/pathology , Mice , Mice, Inbred C57BL , Peptide Fragments/metabolism , Peptide Fragments/pharmacology , Physical Conditioning, Animal , Protein Multimerization/physiology , Recognition, Psychology/drug effects , Recognition, Psychology/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...